uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 24, 2012

Garlic Supplement Maker Warned For Misbranding and Drug Claims

On October 10, 2012, the FDA issued a letter to dietary supplement manufacturer Garlic Wise because statements made in a brochure about the company’s Alli-C garlic supplement promote the product as a drug. Alli-C was also found to be misbranded due to inadequate directions for use.

Alli-C contains a stabilized form of allicin, a compound found in garlic. It was promoted for the prevention and treatment of viral infections including colds and cold sores, bacterial infections including MRSA, Clostridium difficile, Escherichia coli, Salmonella, Streptococcus and Helicobacter pylori and conditions such as arthritis, gum disease and Lyme’s disease.

See’s Review of Garlic Supplements for tests of related products.

For more information about this warning letter, use the link below.